← Back to patent-cliff list
Intravenous Melatonin (Cessatech)
Tier C — Watch / tradeIntravenous Melatonin (Cessatech)
Cessatech A/S
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Melatonin receptor
Indications (approved)：苏醒期谵妄
Regional status
US
-
EU
Phase III
2025-01-21
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Intravenous Melatonin (Cessatech)?
Approved indications include: 苏醒期谵妄.
When does the Intravenous Melatonin (Cessatech) patent expire?
No public expiry year is available for Intravenous Melatonin (Cessatech) yet; this page updates once verified.
How do I get a quote for Intravenous Melatonin (Cessatech) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01